User Reviews for Eculizumab
Also known as: Soliris
| Condition | Avg. Rating | Reviews | Compare | |
|---|---|---|---|---|
| Paroxysmal Nocturnal Hemoglobinuria | 5.0 | 1 reviews | 2 medications | |
| Myasthenia Gravis | 1 reviews | 8 medications | ||
| Summary of Eculizumab reviews | 5.0 | 2 reviews | ||
Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.
Soliris (eculizumab) for Myasthenia Gravis: “I started taking SOLIRIS January 2019 and by July 2019 I had throat cancer which was undetectable by CT scan but was confirmed by tissue biopsy.”
This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.
More about eculizumab
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Compare Alternatives
- En Español
- Drug class: selective immunosuppressants
Consumer resources
Other brands: Soliris
Soliris (eculizumab) for Paroxysmal Nocturnal Hemoglobinuria: “This drug is for Paroxysmal Nocturnal Hemoglobinuria (PNH) but disease is heterogeneous. I feel worse being on it. Doctors push it-patients just do it. It is too much work. I never should have started.”